Acute Lymphoblastic Leukaemia: A Case Report of Long-term Disease-free Survival in a Resource Limited Setting

E. Jatau, D. Joseph, J. Egesie, O. Damulak, T. Piwuna, A. Onoja, O. Ewuga, VT Ma'an, Z. Ayuba, C. Okeke
{"title":"Acute Lymphoblastic Leukaemia: A Case Report of Long-term Disease-free Survival in a Resource Limited Setting","authors":"E. Jatau, D. Joseph, J. Egesie, O. Damulak, T. Piwuna, A. Onoja, O. Ewuga, VT Ma'an, Z. Ayuba, C. Okeke","doi":"10.46912/jbrcp.182","DOIUrl":null,"url":null,"abstract":"Acute Lymphoblastic Leukaemia (ALL) a malignant proliferation of immature lymphoid cells is a biologically heterogeneous disorder with variable outcomes in adults. We present a case report of a 54-year-old woman who presented with fever, anaemia and peripheral lymphadenopathy of four weeks duration, and was managed for disseminated tuberculosis initially. Full blood count and bone marrow aspiration cytology constituted part of her initial investigations and were found to be in keeping with acute lymphoblastic leukaemia (ALL-L3). Patient had supportive treatment and managed with Cyclophosphamide, Vincristine (Oncovin), Cytosine Arabinoside and Prednisolone (COAP Regimen), achieved complete clinical and haematologic remission, and has remained disease free after consolidation and maintenance therapy. No evidence of haematologic or clinical relapse at five years and currently in her ninth-year post diagnosis and treatment. With high index of suspicion, timely investigation and referral, satisfactory outcomes are achievable in managing some patients with acute lymphoblastic leukaemia.","PeriodicalId":301476,"journal":{"name":"Journal of BioMedical Research and Clinical Practice","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of BioMedical Research and Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46912/jbrcp.182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Acute Lymphoblastic Leukaemia (ALL) a malignant proliferation of immature lymphoid cells is a biologically heterogeneous disorder with variable outcomes in adults. We present a case report of a 54-year-old woman who presented with fever, anaemia and peripheral lymphadenopathy of four weeks duration, and was managed for disseminated tuberculosis initially. Full blood count and bone marrow aspiration cytology constituted part of her initial investigations and were found to be in keeping with acute lymphoblastic leukaemia (ALL-L3). Patient had supportive treatment and managed with Cyclophosphamide, Vincristine (Oncovin), Cytosine Arabinoside and Prednisolone (COAP Regimen), achieved complete clinical and haematologic remission, and has remained disease free after consolidation and maintenance therapy. No evidence of haematologic or clinical relapse at five years and currently in her ninth-year post diagnosis and treatment. With high index of suspicion, timely investigation and referral, satisfactory outcomes are achievable in managing some patients with acute lymphoblastic leukaemia.
急性淋巴细胞白血病:在资源有限的情况下长期无病生存的病例报告
急性淋巴母细胞白血病(ALL)是一种未成熟淋巴样细胞的恶性增殖,是一种生物学异质性疾病,在成人中具有不同的结局。我们提出一个病例报告,54岁的妇女谁提出了发烧,贫血和周围淋巴结病持续四周,并被管理为播散性结核病最初。全血细胞计数和骨髓抽吸细胞学是她最初检查的一部分,发现与急性淋巴细胞白血病(ALL-L3)一致。患者接受了环磷酰胺、长春新碱(Oncovin)、阿拉伯糖胞嘧啶和强的松龙(COAP方案)的支持治疗,临床和血液学完全缓解,并在巩固和维持治疗后保持无疾病。在诊断和治疗后的第5年和目前是第9年,没有血液学或临床复发的证据。对部分急性淋巴细胞白血病患者的治疗,由于怀疑程度高,及时调查和转诊,取得了满意的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信